Shenzhen Glory Medical Co Ltd (002551) - Net Assets
Based on the latest financial reports, Shenzhen Glory Medical Co Ltd (002551) has net assets worth CN¥2.61 Billion CNY (≈ $381.98 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.25 Billion ≈ $474.85 Million USD) and total liabilities (CN¥634.68 Million ≈ $92.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shenzhen Glory Medical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.61 Billion |
| % of Total Assets | 80.44% |
| Annual Growth Rate | 21.12% |
| 5-Year Change | -24.11% |
| 10-Year Change | 20.48% |
| Growth Volatility | 76.37 |
Shenzhen Glory Medical Co Ltd - Net Assets Trend (2007–2025)
This chart illustrates how Shenzhen Glory Medical Co Ltd's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Shenzhen Glory Medical Co Ltd to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Shenzhen Glory Medical Co Ltd (2007–2025)
The table below shows the annual net assets of Shenzhen Glory Medical Co Ltd from 2007 to 2025. For live valuation and market cap data, see 002551 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.62 Billion ≈ $382.74 Million |
-5.77% |
| 2024-12-31 | CN¥2.78 Billion ≈ $406.19 Million |
+1.02% |
| 2023-12-31 | CN¥2.75 Billion ≈ $402.08 Million |
-8.39% |
| 2022-12-31 | CN¥3.00 Billion ≈ $438.89 Million |
-12.97% |
| 2021-12-31 | CN¥3.45 Billion ≈ $504.31 Million |
-5.46% |
| 2020-12-31 | CN¥3.65 Billion ≈ $533.44 Million |
+29.45% |
| 2019-12-31 | CN¥2.82 Billion ≈ $412.08 Million |
+1.39% |
| 2018-12-31 | CN¥2.78 Billion ≈ $406.45 Million |
+3.91% |
| 2017-12-31 | CN¥2.67 Billion ≈ $391.17 Million |
+23.14% |
| 2016-12-31 | CN¥2.17 Billion ≈ $317.67 Million |
+37.28% |
| 2015-12-31 | CN¥1.58 Billion ≈ $231.41 Million |
+8.55% |
| 2014-12-31 | CN¥1.46 Billion ≈ $213.18 Million |
+9.13% |
| 2013-12-31 | CN¥1.33 Billion ≈ $195.34 Million |
+9.45% |
| 2012-12-31 | CN¥1.22 Billion ≈ $178.47 Million |
+3.31% |
| 2011-12-31 | CN¥1.18 Billion ≈ $172.76 Million |
+327.76% |
| 2010-12-31 | CN¥276.00 Million ≈ $40.39 Million |
+20.41% |
| 2009-12-31 | CN¥229.22 Million ≈ $33.54 Million |
+33.12% |
| 2008-12-31 | CN¥172.19 Million ≈ $25.20 Million |
+107.34% |
| 2007-12-31 | CN¥83.05 Million ≈ $12.15 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shenzhen Glory Medical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 588.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥305.75 Million | 12.31% |
| Other Components | CN¥2.18 Billion | 87.69% |
| Total Equity | CN¥2.48 Billion | 100.00% |
Shenzhen Glory Medical Co Ltd Competitors by Market Cap
The table below lists competitors of Shenzhen Glory Medical Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Avidia Bancorp, Inc.
NYSE:AVBC
|
$360.06 Million |
|
BIGLARI HLDGS CL. A
F:SQ7A
|
$360.35 Million |
|
Cambi ASA
OL:CAMBI
|
$360.36 Million |
|
Civeo Corp
NYSE:CVEO
|
$360.36 Million |
|
Dine Brands Global Inc
NYSE:DIN
|
$360.01 Million |
|
LTC Co.Ltd
KQ:170920
|
$359.97 Million |
|
Kumho HT Inc
KO:214330
|
$359.94 Million |
|
Tonnellerie Francois Freres SA
PA:TFF
|
$359.89 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shenzhen Glory Medical Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,639,101,461 to 2,484,231,529, a change of -154,869,932 (-5.9%).
- Net loss of 139,581,672 reduced equity.
- Dividend payments of 22,362,939 reduced retained earnings.
- Other comprehensive income increased equity by 53,959,884.
- Other factors decreased equity by 46,885,205.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-139.58 Million | -5.62% |
| Dividends Paid | CN¥22.36 Million | -0.9% |
| Other Comprehensive Income | CN¥53.96 Million | +2.17% |
| Other Changes | CN¥-46.89 Million | -1.89% |
| Total Change | CN¥- | -5.87% |
Book Value vs Market Value Analysis
This analysis compares Shenzhen Glory Medical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.99x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 13.45x to 0.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | CN¥0.22 | CN¥2.91 | x |
| 2008-12-31 | CN¥0.38 | CN¥2.91 | x |
| 2009-12-31 | CN¥0.48 | CN¥2.91 | x |
| 2010-12-31 | CN¥0.56 | CN¥2.91 | x |
| 2011-12-31 | CN¥1.90 | CN¥2.91 | x |
| 2012-12-31 | CN¥1.87 | CN¥2.91 | x |
| 2013-12-31 | CN¥1.88 | CN¥2.91 | x |
| 2014-12-31 | CN¥2.05 | CN¥2.91 | x |
| 2015-12-31 | CN¥2.16 | CN¥2.91 | x |
| 2016-12-31 | CN¥2.63 | CN¥2.91 | x |
| 2017-12-31 | CN¥3.38 | CN¥2.91 | x |
| 2018-12-31 | CN¥3.48 | CN¥2.91 | x |
| 2019-12-31 | CN¥2.76 | CN¥2.91 | x |
| 2020-12-31 | CN¥3.56 | CN¥2.91 | x |
| 2021-12-31 | CN¥3.59 | CN¥2.91 | x |
| 2022-12-31 | CN¥3.26 | CN¥2.91 | x |
| 2023-12-31 | CN¥3.09 | CN¥2.91 | x |
| 2024-12-31 | CN¥2.98 | CN¥2.91 | x |
| 2025-12-31 | CN¥2.94 | CN¥2.91 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shenzhen Glory Medical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.62%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -12.96%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.34x
- Recent ROE (-5.62%) is below the historical average (5.89%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 26.90% | 18.92% | 0.55x | 2.57x | CN¥13.83 Million |
| 2008 | 14.19% | 17.47% | 0.43x | 1.87x | CN¥7.12 Million |
| 2009 | 17.42% | 19.13% | 0.52x | 1.76x | CN¥16.99 Million |
| 2010 | 16.85% | 17.18% | 0.55x | 1.77x | CN¥18.86 Million |
| 2011 | 3.74% | 12.67% | 0.26x | 1.13x | CN¥-73.82 Million |
| 2012 | 4.81% | 13.84% | 0.28x | 1.26x | CN¥-63.02 Million |
| 2013 | 5.90% | 10.09% | 0.36x | 1.61x | CN¥-51.28 Million |
| 2014 | 7.49% | 8.76% | 0.50x | 1.73x | CN¥-34.24 Million |
| 2015 | 8.32% | 7.14% | 0.56x | 2.07x | CN¥-23.98 Million |
| 2016 | 6.47% | 5.87% | 0.48x | 2.30x | CN¥-62.26 Million |
| 2017 | 7.78% | 8.73% | 0.47x | 1.91x | CN¥-49.98 Million |
| 2018 | 4.21% | 5.99% | 0.40x | 1.77x | CN¥-134.36 Million |
| 2019 | 2.56% | 3.90% | 0.32x | 2.02x | CN¥-173.90 Million |
| 2020 | 5.44% | 7.15% | 0.45x | 1.70x | CN¥-136.00 Million |
| 2021 | 1.43% | 2.49% | 0.36x | 1.59x | CN¥-267.54 Million |
| 2022 | -11.17% | -24.15% | 0.30x | 1.55x | CN¥-583.77 Million |
| 2023 | -5.70% | -12.48% | 0.30x | 1.50x | CN¥-410.31 Million |
| 2024 | 0.84% | 1.54% | 0.37x | 1.47x | CN¥-241.63 Million |
| 2025 | -5.62% | -12.96% | 0.32x | 1.34x | CN¥-388.00 Million |
Industry Comparison
This section compares Shenzhen Glory Medical Co Ltd's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $7,586,300,691
- Average return on equity (ROE) among peers: 15.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shenzhen Glory Medical Co Ltd (002551) | CN¥2.61 Billion | 26.90% | 0.24x | $360.03 Million |
| China National Accord Medicines Corp Ltd (000028) | $1.84 Billion | 25.87% | 4.05x | $1.62 Billion |
| Shandong Realcan Pharmaceutical Co Ltd (002589) | $5.42 Billion | 0.30% | 1.65x | $598.91 Million |
| China National Accord Medicines Corp Ltd (200028) | $20.98 Billion | 7.62% | 1.27x | $125.79 Million |
| Qingdao Baheal Medical INC. (301015) | $1.50 Billion | 18.20% | 1.70x | $1.57 Billion |
| China Meheco Co Ltd (600056) | $122.32 Million | 38.37% | 2.06x | $2.02 Billion |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) | $28.21 Billion | 10.34% | 1.12x | $4.38 Billion |
| China National Medicines Corp Ltd (600511) | $468.65 Million | 6.99% | 1.32x | $3.09 Billion |
| Liaoning Cheng Da Co Ltd (600739) | $8.07 Billion | 15.60% | 0.27x | $2.33 Billion |
| Jointown Pharmaceutical Group Co Ltd (600998) | $1.67 Billion | 17.81% | 3.29x | $3.59 Billion |
About Shenzhen Glory Medical Co Ltd
Shenzhen Glory Medical Co.,Ltd. offers hospital construction and medical system integrated solutions in China and internationally. It operates through Medical Products, Medical Services, and Health Industry segments. The company is involved in the planning, design, management, and implementation of hospital construction projects; installation of medical professional engineering projects; and medi… Read more